nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—PCYT2—brain—conduct disorder	0.0903	0.162	CbGeAlD
Lamivudine—PGK1—brain—conduct disorder	0.0776	0.139	CbGeAlD
Lamivudine—NT5C—brain—conduct disorder	0.0655	0.118	CbGeAlD
Lamivudine—PCYT1A—brain—conduct disorder	0.0615	0.11	CbGeAlD
Lamivudine—NME1—brain—conduct disorder	0.0411	0.0738	CbGeAlD
Lamivudine—CMPK1—brain—conduct disorder	0.0396	0.0711	CbGeAlD
Lamivudine—NME2—brain—conduct disorder	0.0387	0.0695	CbGeAlD
Lamivudine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0291	0.0657	CbGpPWpGaD
Lamivudine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0289	0.0653	CbGpPWpGaD
Lamivudine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0271	0.0613	CbGpPWpGaD
Lamivudine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0269	0.0608	CbGpPWpGaD
Lamivudine—SLC22A6—brain—conduct disorder	0.0258	0.0464	CbGeAlD
Lamivudine—PGK1—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.0224	0.0506	CbGpPWpGaD
Lamivudine—DCK—brain—conduct disorder	0.0197	0.0354	CbGeAlD
Lamivudine—ABCC3—brain—conduct disorder	0.0189	0.0339	CbGeAlD
Lamivudine—SLC22A1—brain—conduct disorder	0.0168	0.0302	CbGeAlD
Lamivudine—SLC22A3—brain—conduct disorder	0.0161	0.0289	CbGeAlD
Lamivudine—ABCC4—brain—conduct disorder	0.0156	0.028	CbGeAlD
Lamivudine—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0151	0.0341	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0149	0.0337	CbGpPWpGaD
Lamivudine—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0141	0.0318	CbGpPWpGaD
Lamivudine—SLC22A3—Synaptic Vesicle Pathway—SLC6A4—conduct disorder	0.0139	0.0314	CbGpPWpGaD
Lamivudine—ABCC1—brain—conduct disorder	0.0133	0.0239	CbGeAlD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.0132	0.0298	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0113	0.0255	CbGpPWpGaD
Lamivudine—ABCG2—brain—conduct disorder	0.011	0.0198	CbGeAlD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—EP300—conduct disorder	0.00971	0.0219	CbGpPWpGaD
Lamivudine—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00767	0.0173	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—EP300—conduct disorder	0.00736	0.0166	CbGpPWpGaD
Lamivudine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00715	0.0161	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—CGA—conduct disorder	0.00664	0.015	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—CGA—conduct disorder	0.00664	0.015	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—CGA—conduct disorder	0.00664	0.015	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—SLC6A4—conduct disorder	0.00551	0.0125	CbGpPWpGaD
Lamivudine—ABCB1—brain—conduct disorder	0.00543	0.00974	CbGeAlD
Lamivudine—PGK1—Metabolism—CGA—conduct disorder	0.00541	0.0122	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—SLC6A4—conduct disorder	0.00518	0.0117	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—CGA—conduct disorder	0.00503	0.0114	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00461	0.0104	CbGpPWpGaD
Lamivudine—NME2—Metabolism—CGA—conduct disorder	0.0046	0.0104	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.00437	0.00987	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00429	0.00969	CbGpPWpGaD
Lamivudine—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00396	0.00895	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00363	0.0082	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.00353	0.00797	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CGA—conduct disorder	0.00349	0.00788	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00329	0.00743	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00312	0.00704	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00302	0.00683	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—COMT—conduct disorder	0.003	0.00677	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—COMT—conduct disorder	0.003	0.00677	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—COMT—conduct disorder	0.003	0.00677	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—MAOA—conduct disorder	0.00298	0.00672	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—MAOA—conduct disorder	0.00298	0.00672	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—MAOA—conduct disorder	0.00298	0.00672	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00289	0.00652	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00278	0.00628	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00261	0.0059	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—COMT—conduct disorder	0.00244	0.00552	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00244	0.00552	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—MAOA—conduct disorder	0.00243	0.00548	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CGA—conduct disorder	0.00239	0.0054	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00233	0.00527	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00228	0.00514	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—COMT—conduct disorder	0.00227	0.00513	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—MAOA—conduct disorder	0.00226	0.00509	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00222	0.00501	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0022	0.00498	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0022	0.00497	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00219	0.00494	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00218	0.00492	CbGpPWpGaD
Lamivudine—NME2—Metabolism—COMT—conduct disorder	0.00208	0.00469	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00207	0.00467	CbGpPWpGaD
Lamivudine—NME2—Metabolism—MAOA—conduct disorder	0.00206	0.00466	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00205	0.00463	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00192	0.00433	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0019	0.00428	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00177	0.00399	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—COMT—conduct disorder	0.0017	0.00384	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00169	0.00381	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—COMT—conduct disorder	0.00158	0.00358	CbGpPWpGaD
Lamivudine—NME1—Metabolism—COMT—conduct disorder	0.00157	0.00356	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00157	0.00355	CbGpPWpGaD
Lamivudine—NME1—Metabolism—MAOA—conduct disorder	0.00156	0.00353	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CGA—conduct disorder	0.00151	0.00341	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CGA—conduct disorder	0.00139	0.00314	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—EP300—conduct disorder	0.00129	0.0029	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—EP300—conduct disorder	0.00129	0.0029	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—EP300—conduct disorder	0.00129	0.0029	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00126	0.00285	CbGpPWpGaD
Lamivudine—PGK1—Disease—EP300—conduct disorder	0.00125	0.00283	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CGA—conduct disorder	0.00109	0.00246	CbGpPWpGaD
Lamivudine—DCK—Metabolism—COMT—conduct disorder	0.00108	0.00244	CbGpPWpGaD
Lamivudine—DCK—Metabolism—MAOA—conduct disorder	0.00107	0.00242	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—EP300—conduct disorder	0.00105	0.00237	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00104	0.00234	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—EP300—conduct disorder	0.000974	0.0022	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CGA—conduct disorder	0.000957	0.00216	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CGA—conduct disorder	0.000947	0.00214	CbGpPWpGaD
Lamivudine—NME2—Metabolism—EP300—conduct disorder	0.000891	0.00201	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CGA—conduct disorder	0.000883	0.00199	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—COMT—conduct disorder	0.000682	0.00154	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—MAOA—conduct disorder	0.000677	0.00153	CbGpPWpGaD
Lamivudine—NME1—Metabolism—EP300—conduct disorder	0.000675	0.00152	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—COMT—conduct disorder	0.000627	0.00142	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—EP300—conduct disorder	0.000623	0.00141	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MAOA—conduct disorder	0.000622	0.00141	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000604	0.00136	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000539	0.00122	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CGA—conduct disorder	0.000518	0.00117	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—COMT—conduct disorder	0.000491	0.00111	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MAOA—conduct disorder	0.000488	0.0011	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000473	0.00107	CbGpPWpGaD
Lamivudine—DCK—Metabolism—EP300—conduct disorder	0.000463	0.00105	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—COMT—conduct disorder	0.000432	0.000976	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MAOA—conduct disorder	0.000429	0.000969	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—COMT—conduct disorder	0.000428	0.000966	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MAOA—conduct disorder	0.000425	0.000959	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—COMT—conduct disorder	0.000399	0.0009	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MAOA—conduct disorder	0.000396	0.000894	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—EP300—conduct disorder	0.000292	0.00066	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—EP300—conduct disorder	0.000269	0.000607	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EP300—conduct disorder	0.000251	0.000568	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—COMT—conduct disorder	0.000234	0.000528	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MAOA—conduct disorder	0.000232	0.000524	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—EP300—conduct disorder	0.000211	0.000476	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—EP300—conduct disorder	0.000185	0.000419	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—EP300—conduct disorder	0.000183	0.000414	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—EP300—conduct disorder	0.000171	0.000386	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—EP300—conduct disorder	0.0001	0.000226	CbGpPWpGaD
